VeriSIM Life CEO Dr. Jo Varshney Shares Pioneering Approach to Business and Life with MSNBC Mika Brzezinski’s Know Your Value Platform

SAN FRANCISCO–(BUSINESS WIRE)–VeriSIM Life (VeriSIM) www.verisimlife.com, the leading Artificial Intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, is pleased to announce that its CEO, Dr. Jo Varshney, is featured on MSNBC’s Know Your Value platform where she discussed with Mika Brzezinski, co-host of MSNBC’s Morning Joe, her professional and personal experiences that have … [Read more…]

Global Y 27632 Dihydrochloride Markets, 2021-2022 & Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Y 27632 Dihydrochloride Market 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The global Y 27632 Dihydrochloride market is anticipated to grow at a considerable CAGR during the forecast period. Y-27632 dihydrochloride is an orally active, ATP-competitive inhibitor of Rock-I and Rock-II, with Kis of 220 and 300 nM, respectively. The rising … [Read more…]

Adtalem’s Medical Schools Graduate More Than 750 Medical School Students1 at 2022 Commencement Ceremonies

American University of the Caribbean School of Medicine and Ross University School of Medicine Graduates Help Fill Most Critical Specialties Like Primary Care, 26% are of Underrepresented Races and Ethnicities MIAMI–(BUSINESS WIRE)–Adtalem Global Education’s (NYSE: ATGE) medical schools, American University of the Caribbean School of Medicine (AUC) and Ross University School of Medicine (RUSM) celebrated more than 750 medical … [Read more…]

John Hopkin’s University Publishes Efficacy of QuadraMune™ Ingredient Sulforaphane at Inhibiting Coronavirus in Laboratory Studies

Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of Potential Benefit in SARS-CoV-2 Strains OCEANSIDE, Calif.–(BUSINESS WIRE)–Therapeutic Solutions International, a clinical-stage biotechnology company, commented today on a recent research report from John Hopkins Children’s Center in the peer-reviewed publication Nature journal Communications Biology1. Data generated by the … [Read more…]

QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

QuidelOrtho to participate in the William Blair 42nd Annual Growth Stock Conference June 8, 2022 SAN DIEGO–(BUSINESS WIRE)–QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”) announced completion of the transaction combining Quidel Corporation (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (“Ortho”), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated … [Read more…]

Boehringer Ingelheim Leverages NWO.ai for Additional Insights into Animal Disease Outbreaks

Advanced Insights and Analysis into Emerging and Developing Global Animal Health Needs to Better Support Prediction and Prevention Efforts NEW YORK–(BUSINESS WIRE)–NWO.ai, a leading strategic intelligence platform that is revolutionizing the future of external data for enterprises, today announced that it has exclusively partnered with Boehringer Ingelheim, a global leader in the animal health industry. … [Read more…]

LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting

GUANGZHOU, China–(BUSINESS WIRE)–LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Abstract Number:e16102 Abstract Title:Global multi-center … [Read more…]

Oak Hill Bio to Participate in 2022 Wells Fargo Private Biotech Symposium

OXFORDSHIRE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oak Hill Bio (“Oak Hill”), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, today announced that members of its senior leadership team will participate in virtual one-on-one meetings with investors at the upcoming 2022 Wells Fargo … [Read more…]

Agilent Announces Collaboration with APC on Real-Time Process Monitoring

SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today announced a collaboration agreement with APC Ltd., in which the companies commit to working towards combining their technologies to provide unique workflows to customers that support automated process analysis via liquid chromatography (LC). Agilent has selected to partner with APC, a provider of innovative small molecule … [Read more…]

Novel Assay for Early Detection of Ovarian Cancer From Mercy BioAnalytics Significantly Outperforms CA125 in New Research Presented at ASCO Annual Meeting

Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection NATICK, Mass.–(BUSINESS WIRE)–#asco—Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer (OC) assay substantially outperformed CA125 when distinguishing patients with early-stage high-grade serious ovarian cancer … [Read more…]